MedPath

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

Not Applicable
Completed
Conditions
Chronic Subdural Hematoma
Registration Number
NCT04816591
Lead Sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.
Brief Summary

This is a prospective, multi-center, open-label, randomized controlled study in which subjects can receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of chronic subdural hematomas (cSDH).

Detailed Description

This is a prospective, multi-center, open-label, randomized controlled study in which up to 376 subjects will be randomized to receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of cSDH.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
376
Inclusion Criteria
  • Pre-randomization mRS </= 3
  • Confirmed diagnosis of chronic subdural hematoma
  • Completed informed consent
Exclusion Criteria
  • Acute subdural hematoma
  • Prior treatment of target subdural hematoma
  • Markwalder assessment >/= 3
  • Glasgow Coma Scale < 9
  • Presumed microbial superinfection
  • CT or MRI evidence of intracranial tumor or mass lesion
  • Life expectancy < 1 year
  • Women who are pregnant, lactating, or who are of childbearing age and plan on becoming pregnant during the study
  • Current involvement in another clinical trial that may confound study endpoints

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Effectiveness180 days post procedure

Hematoma recurrence/progression or requiring re-intervention

Secondary Outcome Measures
NameTimeMethod
Safety: Change in mRS180 days post procedure

Change in mRS

Effectiveness180 days post procedure

Reduction of hematoma volume

Trial Locations

Locations (33)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Carondelet St Joseph's Hospital

🇺🇸

Tucson, Arizona, United States

John Muir Physician Network Clinical Research Center

🇺🇸

Walnut Creek, California, United States

Swedish Medical Center

🇺🇸

Englewood, Colorado, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Yale University

🇺🇸

New Haven, Connecticut, United States

George Washington University

🇺🇸

Washington, District of Columbia, United States

Baptist Medical Center

🇺🇸

Jacksonville, Florida, United States

University of Miami - Jackson Memorial Hospital

🇺🇸

Miami, Florida, United States

Advent Health Orlando

🇺🇸

Orlando, Florida, United States

Scroll for more (23 remaining)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.